Abstract
The aim of the study was the quantification of metabolically caused electroencephalographic changes of portal-systemic encephalopathy, a prototype of hepatic encephalopathy. We examined 12 patients with liver cirrhosis before and after implantation of a transjugular intrahepatic portosystemic stent shunt (TIPSS) by means of quantitative digital electroencephalography (EEG). One month after TIPSS implantation, all patients showed an increase in the power of the theta frequency band as well as a decrease in the power of the alpha frequency band. To reduce the error variance, we formed the quotient of the relative power of the theta and alpha frequency band. Theta/alpha quotient values over 0.7 indicate a general change of the EEG with a sensitivity of 93% and a specificity of 87%. The results we have to hand indicate a correlation between the albumin concentration and the theta/alpha quotient 1 and 3 months after TIPSS. No significant correlation was revealed with regard to the Child-Pugh score or the liver function parameters cholinesterase, bilirubin, and prothrombin time. Neither the arterial ammonia concentration nor the performance in the psychometric test showed significance in relation to the theta/alpha quotient. Substances with a high albumin bond and potential neurotoxicity may—in the case of lower albumin levels—be absorbed with increased frequency in the CNS and may be responsible for the observed EEG change.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
American Psychiatric Association. (1994). Diagnostic and Statistical Manual of Mental Disorders, Washington, DC.
Butterworth, R.F. (1996). The neurobiology of hepatic encephalopathy. Semin. Liver. Dis. 16:235-244.
Conn, H.O. (1977). Trailmaking and number-connection tests in the assessment of mental state in portal systemic encephalopathy. Am. J. Dig. Dis. 22:541-550.
Conn, H.O. and Bircher, J. (1994). Hepatic Encephalopathy: Syndromes and Therapies, Medi-Ed Press, Bloomington, IL.
Foley, J.M., Watson, C.W., and Adams, R.D. (1950). Significance of the EEG changes in hepatic coma, Trans. Am. Neurol. Assoc. 75:75-82.
Girard, G. and Butterwoth, R.F. (1993). Portocaval anastomosis results in region-selective loss of glutamine synthetase in brain. Metab. Brain Dis. 8:207-215.
Hazell, A.S. and Butterworth, R.F. (1999). Hepatic encephalopathy: An update of pathophysiologic mechanisms. Proc. Soc. Exp. Biol. Med. 222:99-112.
James, J.H., Ziparo, V., Jeppsson, B., and Fischer, J.E. (1979). Hyperammonaemia, plasma aminoacid imbalance, and blood-brain aminoacid transport: A unified theory of portal-systemic encephalopathy. Lancet 2:772-775.
Mullen, K.D., and Gacad, R. (1996). Hepatic encephalopathy. Gastroenterologist 4:188-202.
Nolte, W., Wiltfang, J., Schindler, C., Münke, H., Unterberg, K., Zumhasch, U., Figulla, H.R., Werner, G., Hartmann, H., and Ramadori, G. (1998). Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: Clinical, laboratory, psychometric, and electroencephalographic investigations. Hepatology 28:1215-1225.
Parsons-Smith, B.G., Summerskill, W.H., Dawson, A.M., and Sherlock, S. (1957). The electroencephalograph in liver disease. Lancet 2:867-871.
Pugh, R.N., Murray-Lyon, I.M., Dawson, J.L., Pietroni, M.C., and Williams, R. (1973). Transsection of the oesophagus for bleeding oesophageal varices. Br. J. Surg. 60:646-649.
Quero, J.C. and Schalm, S.W. (1996). Subclinical hepatic encephalopathy. Semin. Liver Dis. 16:321-328.
Schafer, D.F. and Jones, E.A. (1990). Hepatology. A Textbook of Liver Disease, W.B. Saunders, Philadelphia.
Van der Rijt, C.C. and Schalm, S.W. (1991). Spectral Analysis in Hepatic Encephalopathy, CRC Press, Boca Raton, Florida.
Van der Rijt, C.C., Schalm, S.W., De Groot, G.H., and De Vlieger, M. (1984). Objective measurement of hepatic encephalopathy by means of automated EEG analysis. Electroencephalogr. Clin. Neurophysiol. 57:423-426.
Weissenborn, K. (1994). Diagnosis and therapy of portosystemic encephalopathy. Schweiz. Rundsch. Med. Prax. 83:1059-1064.
Weissenborn, K., Scholz, M., Hinrichs, H., Wiltfang, J., Schmidt, F.W., and Kunkel, H. (1990). Neurophysiological assessment of early hepatic encephalopathy. Electroencephalogr. Clin. Neurophysiol. 75:289-295.
Wiltfang, J., Nolte, W., von Heppe, J., Bahn, E., Pilz, J., Hajak, G., Ruther, E., and Ramadori, G. (1999). Sleep disorders and portal-systemic encephalopathy following transjugular intrahepatic portosystemic stent shunt in patients with liver cirrhosis. Relation to plasma tryptophan. Adv. Exp. Med. Biol. 467:169-176.
Youden, J.W. (1950). Index rating for diagnostic tests. Cancer 3:32-35.
Young, S.N., Lal, S., Sourkes, T.L., Feldmuller, F., Aronoff, A., and Martin, J.B. (1975). Relationships between tryptophan in serum and CSF, and 5-hydroxyindoleacetic acid in CSF of man: Effect of cirrhosis of liver and probenecid administration. J. Neurol. Nerosurg. Psychiatry 38:322-330.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bahn, E., Nolte, W., Kurth, C. et al. Quantification of the Electroencephalographic Theta/Alpha Ratio for the Assessment of Portal-Systemic Encephalopathy Following Implantation of Transjugular Intrahepatic Portosystemic Stent Shunt (TIPSS). Metab Brain Dis 17, 19–28 (2002). https://doi.org/10.1023/A:1014048229754
Issue Date:
DOI: https://doi.org/10.1023/A:1014048229754